Jiutian Chemical Group Limited AI Stock Analysis
Want to see SG:C8R full AI Analyst Report?
Jiutian Chemical Group Limited (C8R) AI Stock Analysis
Jiutian Chemical Group Limited
(SGX:C8R)
The score of 37 reflects a company facing a severe fundamental crisis with collapsing revenues, negative margins, and persistent cash burn. This distress is further compounded by a strongly bearish technical downtrend below all major moving averages and an unfavorable valuation profile due to ongoing net losses.
Jiutian Chemical Group Limited (C8R) vs. iShares MSCI Singapore ETF (EWS)
- Market Cap
- SGD 25.85M
- Dividend Yield
- ―
- Average Volume (3M)
- 863.69K
- Price to Earnings (P/E)
- -0.6
- Beta (1Y)
- 1.36
- Revenue Growth
- -69.91%
- EPS Growth
- -13.56%
- Country
- Singapore
- Employees
- 200
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
Jiutian Chemical Group Limited Business Overview & Revenue Model
Company Description
Jiutian Chemical Group Limited, established in Singapore in 1994, operates as an investment holding company with its primary chemical manufacturing and sales activities located in the People's Republic of China. The company's product portfolio encomp...
How the Company Makes Money
Jiutian Chemical Group Limited makes money primarily by manufacturing chemical products and selling them to industrial customers. Its revenue is mainly generated from (1) product sales: income from selling its manufactured chemical products, typicall...
Jiutian Chemical Group Limited Financial Statement Overview
Summary
Financials indicate severe distress with a 56% YoY revenue drop, negative gross margins, and deeply negative free cash flow, despite the company maintaining relatively low debt leverage.
Income Statement
10Very NegativeBalance Sheet
35NegativeCash Flow
15Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 393.13M | 108.43M | 243.76M | 598.56M | 2.43B | 2.17B |
| Gross Profit | -147.20M | -108.72M | -82.26M | -260.18M | 708.41M | 675.62M |
| EBITDA | -141.98M | -101.49M | -118.22M | -321.76M | 696.61M | 517.79M |
| Net Income | -162.31M | -239.63M | -147.80M | -344.64M | 490.50M | 324.90M |
Balance Sheet | ||||||
| Total Assets | 1.42B | 626.61M | 1.05B | 1.29B | 1.99B | 1.89B |
| Cash, Cash Equivalents and Short-Term Investments | 698.48M | 198.16M | 400.41M | 529.62M | 1.11B | 773.55M |
| Total Debt | 234.88M | 127.62M | 289.32M | 265.88M | 134.64M | 228.18M |
| Total Liabilities | 469.16M | 248.45M | 427.02M | 523.23M | 764.65M | 1.08B |
| Stockholders Equity | 948.17M | 378.31M | 618.04M | 765.84M | 1.22B | 816.21M |
Cash Flow | ||||||
| Free Cash Flow | -356.18M | -155.06M | -171.63M | -511.23M | 424.05M | 633.54M |
| Operating Cash Flow | -328.39M | -129.87M | -81.58M | -385.65M | 434.01M | 655.81M |
| Investing Cash Flow | -27.72M | -24.57M | -89.54M | -125.70M | -9.85M | -27.68M |
| Financing Cash Flow | -53.04M | -160.50M | 32.87M | -732.00K | -95.52M | -110.89M |
Jiutian Chemical Group Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 40.54 is Neutral, neither overbought nor oversold. The STOCH value of -150.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C8R.
Jiutian Chemical Group Limited Peers Comparison
Overall Rating
SG:QES72Outperform
SG:C0559Neutral
SG:M1543Neutral- SG:C8R37Underperform
SG:5WV35Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| SG:QES | 72Outperform | SGD 616.26M | 7.64 | 9.08% | 4.25% | 4.17% | -12.40% |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| SG:C05 | 59Neutral | SGD 35.31M | 22.25 | 1.49% | 1.08% | -7.25% | 95.72% |
| SG:M15 | 43Neutral | SGD 11.35M | -1.30 | -164.44% | ― | 25.81% | -30.34% |
| SG:C8R | 37Underperform | SGD 27.84M | -0.56 | -48.10% | ― | -69.91% | -13.56% |
| SG:5WV | 35Underperform | SGD 11.84M | -10.00 | -81.29% | ― | ― | ― |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SG:C8R | Jiutian Chemical Group Limited | 0.01 | -0.01 | -55.56% | |
| SG:QES | China Sunsine Chemical Holdings Ltd. | 0.64 | -0.12 | -15.34% | |
| SG:C05 | Chemical Industries Far East Ltd. | 0.47 | -0.03 | -6.25% | |
| SG:M15 | Matex International Limited | 0.02 | 0.00 | 0.00% | |
| SG:5DS | MegaChem Ltd. | 0.45 | 0.02 | 3.45% | |
| SG:5WV | AsiaPhos Limited | 0.01 | 0.00 | 0.00% |
Jiutian Chemical Group Limited Corporate Events
Jiutian Chemical Reports Higher Third-Quarter Revenue and Narrower Loss
Jiutian Chemical Group Limited is a chemical-products group involved in methanol, methylamine and DMF. For the three months ended 30 September 2026, revenue increased 46% year on year to RMB 4.09 million, mainly from stock clearance involving those p...
Jiutian Chemical Adjusts Board Line-Up While Keeping Governance Framework Intact
Jiutian Chemical Group Limited has announced changes in its boardroom, highlighted by the resignation of non-executive and independent director Wang Zilong effective 3 November 2026 and the appointment of new non-executive and independent director Li...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 25, 2026